Role of Cytokines in Naive CD4+ T cell Activation
Role of Cytokines in Naive CD4+ T cell Activation
批准号:
7187409
负责人:
James J Moon
金额:
$1.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2007-05-31
关键词:
Antigen-Presenting CellsAntigensCD4 Positive T LymphocytesCellsCytokine ReceptorsCytokine SignalingDataDevelopmentDistantEffector CellFamilyGoalsImmuneImmunologyIn VitroInflammatoryInterleukin-12Interleukin-2MediatingMediator of activation proteinPlayProcessProgram DevelopmentRoleSignal PathwaySignal TransductionSourceStagingSystemT-Cell ActivationT-Cell DevelopmentT-Cell ProliferationT-Lymphocytecytokinecytokine receptor gp130genetic manipulationin vivoresearch studytranscription factor
中文摘要
描述(由申请人提供):本提案的总体目标是阐明细胞因子在体内抗原驱动的初始CD 4 + T细胞活化中的作用。尽管IL-2在体外初始T细胞增殖的引发中的作用已被充分确立,但越来越多的证据表明,在体内,IL-2不是该过程所必需的。我们的假设是,最佳的抗原驱动的幼稚CD 4 + T细胞的增殖在体内由γ共同依赖性细胞因子激活的StatS信号和gp 130依赖性细胞因子激活的Stat 5信号冗余地促进。使用能够在抗原刺激之前对初始CD 4 + T细胞进行遗传操作的体内实验系统,这些候选细胞因子的信号传导功能将被阻断以评估它们在促进增殖和发育成Th效应细胞中的作用。这种策略将避免这些细胞因子在T细胞发育的其他阶段中的多效性作用所引起的并发症,这破坏了对过去体内研究的解释。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to clarify the role of cytokines in antigen-driven naive CD4+ T cell activation in vivo. Despite the well established role of IL-2 in the priming of naive T cell proliferation in vitro, growing evidence suggests that in vivo, IL-2 is not required for this process. Our hypothesis is that optimal antigen-driven proliferation of naive CD4+ T cells is promoted redundantly in vivo by StatS signals activated by gamma common-dependent cytokines, and Stat5 signals activated by gp130-dependent cytokines. Using an in vivo experimental system that enables genetic manipulation of naive CD4+ T cells just prior to antigen stimulation, the signaling functions of these candidate cytokines will be blocked to assess their role in promoting proliferation and development into Th effector cells. This strategy will avoid complications arising from the pleiotropic roles of these cytokines in other stages of T cell development, which have undermined interpretations of past in vivo studies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Biomaterials for modulating the gut microbiome for immune activation
-
批准号:10614059
-
项目类别:
-
资助金额:$48.35万
-
财政年份:2022
-
负责人:James J Moon
-
依托单位:
T cell Tolerance to Enteric Commensal Bacteria
-
批准号:10608196
-
项目类别:
-
资助金额:$50.24万
-
财政年份:2021
-
负责人:James J Moon
-
依托单位:
T cell Tolerance to Enteric Commensal Bacteria
-
批准号:10299254
-
项目类别:
-
资助金额:$50.24万
-
财政年份:2021
-
负责人:James J Moon
-
依托单位:
T cell Tolerance to Enteric Commensal Bacteria
-
批准号:10424555
-
项目类别:
-
资助金额:$50.24万
-
财政年份:2021
-
负责人:James J Moon
-
依托单位:
Elicitation of mucosal immune responses against HIV
-
批准号:9292510
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2016
-
负责人:James J Moon
-
依托单位:
Elicitation of mucosal immune responses against HIV
-
批准号:9752434
-
项目类别:
-
资助金额:$65.33万
-
财政年份:2016
-
负责人:James J Moon
-
依托单位:
Engineering Nanomaterials to Prime Immunity
-
批准号:10063848
-
项目类别:
-
资助金额:$41.02万
-
财政年份:2016
-
负责人:James J Moon
-
依托单位:
Elicitation of mucosal immune responses against HIV
-
批准号:9539522
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2016
-
负责人:James J Moon
-
依托单位:
Elicitation of mucosal immune responses against HIV
-
批准号:9271737
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2016
-
负责人:James J Moon
-
依托单位:
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme
-
批准号:9348653
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2016
-
负责人:James J Moon
-
依托单位:
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme
-
批准号:9512575
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2016
-
负责人:James J Moon
-
依托单位:
Delivery of Particle Vaccines to Control Trafficking Patterns of T Cells
-
批准号:8226138
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2013
-
负责人:James J Moon
-
依托单位:
Self Antigen Specific CD4 Positive T cells
-
批准号:8651025
-
项目类别:
-
资助金额:$41.06万
-
财政年份:2013
-
负责人:James J Moon
-
依托单位:
Delivery of Particle Vaccines to Control Trafficking Patterns of T Cells
-
批准号:8600957
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2013
-
负责人:James J Moon
-
依托单位:
Self Antigen Specific CD4 Positive T cells
-
批准号:9177742
-
项目类别:
-
资助金额:$41.06万
-
财政年份:2013
-
负责人:James J Moon
-
依托单位:
Self Antigen Specific CD4 Positive T cells
-
批准号:8774179
-
项目类别:
-
资助金额:$41.06万
-
财政年份:2013
-
负责人:James J Moon
-
依托单位:
Tetramer Core
-
批准号:8196496
-
项目类别:
-
资助金额:$15.07万
-
财政年份:2011
-
负责人:James J Moon
-
依托单位:
Role of Cytokines in Naive CD4+ T cell Activation
-
批准号:7055595
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2006
-
负责人:James J Moon
-
依托单位:
Tetramer Core
-
批准号:8381647
-
项目类别:
-
资助金额:$9.14万
-
财政年份:--
-
负责人:James J Moon
-
依托单位:
Tetramer Core
-
批准号:8707954
-
项目类别:
-
资助金额:$9.39万
-
财政年份:--
-
负责人:James J Moon
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: